Effect of pneumococcal conjugate vaccine introduction on childhood pneumonia mortality in Brazil: a retrospective observational study

The Lancet Global Health - Tập 7 - Trang e249-e256 - 2019
Cynthia Schuck-Paim1, Robert J Taylor1, Wladimir J Alonso2, Daniel M Weinberger3, Lone Simonsen4,5
1Sage Analytica, Portland, ME, USA
2Department of Genetics and Evolutionary Biology, University of São Paulo, São Paulo, Brazil
3Department of Epidemiology of Microbial Diseases, Yale University School of Public Health, New Haven, CT, USA
4Department of Global Health, George Washington University, Washington DC, USA
5Department of Science and Environment, Roskilde University, Roskilde, Denmark

Tài liệu tham khảo

Liu, 2016, Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals, Lancet, 388, 3027, 10.1016/S0140-6736(16)31593-8 Troeger, 2017, Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015, Lancet Infect Dis, 17, 909, 10.1016/S1473-3099(17)30276-1 Haasis, 2015, Do pneumococcal conjugate vaccines represent good value for money in a lower-middle income country? A cost-utility analysis in the Philippines, PLoS One, 10, e0131156, 10.1371/journal.pone.0131156 Loo, 2014, Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia, Pediatr Infect Dis J, 33, S140, 10.1097/INF.0000000000000082 De Oliveira, 2016, Impact and effectiveness of 10 and 13-valent pneumococcal conjugate vaccines on hospitalization and mortality in children aged less than 5 years in Latin American countries: a systematic review, PLoS One, 11, e0166736, 10.1371/journal.pone.0166736 Feikin, 2013, Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites, PLoS Med, 10, e1001517, 10.1371/journal.pmed.1001517 2012, Pneumococcal vaccines WHO position paper—2012—recommendations, Vaccine, 30, 4717, 10.1016/j.vaccine.2012.04.093 Wonodi, 2012, Evaluation of risk factors for severe pneumonia in children: the pneumonia etiology research for child health study, Clin Infect Dis, 54, S124, 10.1093/cid/cir1067 Alonso, 2017, Popweaver: a program for interpolation and visualization of census and other sparsely collected data, J Popul Res, 34, 303, 10.1007/s12546-017-9186-3 Schuck-Paim, 2013, Use of near-real-time medical claims data to generate timely vaccine coverage estimates in the US: the dynamics of PCV13 vaccine uptake, Vaccine, 31, 5983, 10.1016/j.vaccine.2013.10.038 Bruhn, 2017, Estimating the population-level impact of vaccines using synthetic controls, Proc Natl Acad Sci USA, 114, 1524, 10.1073/pnas.1612833114 de Frias, 2013, Correcting vital information: estimating infant mortality, Brazil, 2000–2009, Rev Saude Publica, 47, 1048, 10.1590/S0034-89102013000901048 Cutts, 2002, Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial, Lancet, 365, 1139, 10.1016/S0140-6736(05)71876-6 Kupek, 2016, O impacto da vacina pneumocócica PCV10 na redução da mortalidade por pneumonia em crianças menores de um ano em Santa Catarina, Brasil, Cad Saude Publica, 32, e00131414, 10.1590/0102-311X00131414 Diaz, 2016, Effectiveness of the 10-valent pneumococcal conjugate vaccine (PCV-10) in children in Chile: a nested case-control study using nationwide pneumonia morbidity and mortality surveillance data, PLoS One, 11, e0153141, 10.1371/journal.pone.0153141 Becker-Dreps, 2014, Changes in childhood pneumonia and infant mortality rates following introduction of the 13-valent pneumococcal conjugate vaccine in Nicaragua, Pediatr Infect Dis J, 33, 637, 10.1097/INF.0000000000000269 Becker-Dreps, 2017, Changes in the incidence of pneumonia, bacterial meningitis, and infant mortality 5 years following introduction of the 13-valent pneumococcal conjugate vaccine in a “3+0” schedule, PLoS One, 12, e0183348, 10.1371/journal.pone.0183348 Suarez, 2016, Impact of pneumococcal conjugate vaccine in children morbidity and mortality in Peru: time series analyses, Vaccine, 34, 4738, 10.1016/j.vaccine.2016.07.027 Klugman, 2003, A Trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection, N Engl J Med, 349, 1341, 10.1056/NEJMoa035060 Tregnaghi, 2014, Efficacy of pneumococcal nontypable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in young Latin American children: a double-blind randomized controlled trial, PLoS Med, 11, e1001657, 10.1371/journal.pmed.1001657 Santa-Ana-Tellez, 2013, Impact of over-the-counter restrictions on antibiotic consumption in Brazil and Mexico, PLoS One, 8, e75550, 10.1371/journal.pone.0075550